Delivery Order SPE2DB22D3501-SPE2DB24FUD25
Award Date 1/11/24
Potential Completion Date 2/2/24
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,344.30, is for the delivery of Lorbrena 100 mg tablets over a period ending on March 19, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a $11,624.35 delivery order to AmerisourceBergen Drug Corp for the supply of Lorbrena 100 mg tablets (30-count packages) under a firm fixed-price contract. The delivery order is scheduled for completion by September 18, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet federal pharmaceutical procurement...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,578.39, is for the delivery of LORBRENA 100 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,624.35, is for the delivery of LORBRENA 100 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance ending on July 21, 2025. AmerisourceBergen Drug Corp is the prime contractor for this award, which is not set aside for any specific business type....
- This is a $23,248.72 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LORBRENA 100 MG TABLET 30S, a medical supply product, with a period of performance through July 16, 2025. The contract is a firm-fixed-price arrangement and is not set aside for any special designation. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,344.30, is for the supply of LORBRENA 100 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price contract. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,965.33 Firm Fixed Price Delivery Order is for the supply of 4,564,361,949 units of the pharmaceutical product LORBRENA 100 MG TABLET 30S, with a completion date of May 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LORBRENA 100MG TAB 30S, a pharmaceutical product, with a ceiling value of $22,688.62 and a period of performance through March 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award, valued at $21,156.78, is a firm fixed-price delivery order contract for the supply of the medication Lorbrena 100 mg Tablet with a completion date of December 26, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of the pharmaceutical product LORBRENA 100 MG TABLET 30S. The contract has a ceiling value of $42,313.56 and a performance period through April 16, 2024. This delivery order is part of a broader indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a...